摘要
目的研究尿激酶型纤溶酶原激活物(uPA)及其特异受体(uPA-R)和抑制物(PAⅠ-1)与肝细胞癌(HCC)的关系及其在HCC浸润转移中的作用。方法用uPA、PAⅠ-1单克隆抗体和uPA-R多抗分别检测uPA、PAⅠ-1和uPA-R在48例HCC和12例对照组中蛋白水平的表达。结果癌与癌周及对照组比较,uPA、uPA-R和PAⅠ-1膜上免疫染色阳性率明显升高,P<0.05。在侵袭性病例中,uPA和uPA-R阳性为16/22和19/22,与非侵袭性7/26和10/26相比,P分别<0.01和<0.001。癌栓形成和淋巴结转移病例uPA-R阳性分别为8/8和6/6。术后复发病例uPA-R阳性为15/17,与无复发组14/31相比,P<0.01。术后2年死亡患者uPA-R和PAⅠ-1阳性分别为12/12和9/12,与生存组17/36和15/36相比,P分别<0.01和<0.05。在uPA、uPA-R和PAⅠ-1同时阳性病例中,侵袭性肿瘤和术后2年死亡分别占11/15和7/15,与阴性组2/8和0/8相比,P<0.05。结论uPA、uPA-R和PAⅠ-1在HCC中表达明显升高,uPA和uPA-R与HCC浸润转移密切?
Objective To study the relevance of uPA, uPA R and PAⅠ 1 to hepatocellular cancer (HCC). Methods The expression at protein level for uPA, uPA R and PAⅠ 1 was examined in 48 cases of HCC and 12 cases of benign tumors of the liver (as control) immunohistochemically.Results When compared to HCC adjacent normal liver tissue and the control, positive rates of immune staining for uPA, uPA R and PAⅠ 1 on cell membrane were significantly higher in HCC cells ( P <0.05). Posi tive staining of uPA and uPA R was seen in 16 of 22 and 19 of 22 cases of HCC with invasion, respectively ( P <0.01 and <0.001). In 8 of 8 cases with cancer emboli, and in 6 of 6 cases with lymph node metastasis was the expression of uPA R positive. Compared with 2 of 17 cases without recurrence, uPA R was positive in 15 of 17 recurrent cases ( P <0.01). In 36 cases who survived, 17 was positive for uPA R and 15 for PAⅠ 1, while in 12 cases who died 2 years after surgery, 12 and 9 cases were positive for uPA R and PAⅠ 1, respectively ( P <0.01 and <0.05). In 15 cases positive for all three parameters, 11 had cancer invasion and 7 died in 2 years, while in the controls with negative staining 2 had invasion and none died in 2 years ( P <0.05).Conclusion Expression of uPA, uPA R and PAⅠ 1 is increased in HCC, and uPA and uPA R may contribute significantly to HCC invasion and metastasis. uPA R and PAⅠ 1 are associated with poor prognosis.
出处
《中华肿瘤杂志》
CAS
CSCD
北大核心
1998年第1期57-59,共3页
Chinese Journal of Oncology
基金
美国纽约中华医学基金
上海市领先专业基金
关键词
肝肿瘤
肿瘤浸润力
肿瘤转移
UPA
肝细胞癌
Liver neoplasms
Carcinoma
hepatocellalar
Plasminogen activators
Neoplasm invasiveness
Neoplasm metastasis
Immunohistochemistry